Oneness Biotech Co Ltd Market Cap ($691.90 Million)
Market Cap & Net Worth: Oneness Biotech Co Ltd (4743)
Oneness Biotech Co Ltd market cap. Oneness Biotech Co Ltd (TWO:4743) has a market capitalization of $691.90 Million (NT$21.96 Billion) as of November 1, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #10256 globally and #362 in its home market, demonstrating a -5.37% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Oneness Biotech Co Ltd's stock price NT$45.80 by its total outstanding shares 479500000 (479.50 Million). Also see 4743 cash generation efficiency for how efficiently the company converts equity into cash flow.
Oneness Biotech Co Ltd Market Cap History (2015–2026)
Oneness Biotech Co Ltd market cap history from 2015 to 2026. Data shows growth from $518.25 Million to $691.90 Million (3.57% CAGR). Check today's stock price for Oneness Biotech Co Ltd for real-time trading data and today's change.
Oneness Biotech Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Oneness Biotech Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Oneness Biotech Co Ltd growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
6.50x
Oneness Biotech Co Ltd's market cap is 6.50 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $455.21 Million | $5.70 Million | -$14.26 Million | 79.82x | N/A |
| 2017 | $269.41 Million | $2.59 Million | -$155.45 Million | 104.14x | N/A |
| 2018 | $347.05 Million | $18.86 Million | -$235.44 Million | 18.41x | N/A |
| 2019 | $390.18 Million | $13.47 Million | -$328.46 Million | 28.96x | N/A |
| 2020 | $3.20 Billion | $41.60 Million | -$251.68 Million | 76.88x | N/A |
| 2021 | $3.82 Billion | $65.77 Million | -$412.82 Million | 58.02x | N/A |
| 2022 | $3.26 Billion | $1.07 Billion | $359.98 Million | 3.06x | 9.05x |
| 2023 | $2.94 Billion | $86.78 Million | -$1.31 Billion | 33.86x | N/A |
| 2024 | $1.32 Billion | $117.93 Million | -$1.17 Billion | 11.18x | N/A |
| 2025 | $839.94 Million | $129.12 Million | -$1.04 Billion | 6.50x | N/A |
Competitor Companies of 4743 by Market Capitalization
Companies near Oneness Biotech Co Ltd in the global market cap rankings as of November 1, 2026. Also see 4743 total asset value for a full breakdown of the balance sheet.
Key companies related to Oneness Biotech Co Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #182 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $558.88 |
| #371 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $927.89 |
| #412 | CSL Ltd | AU:CSL | $68.91 Billion | AU$200.73 |
| #495 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $221.72 |
Market Capitalization of Oneness Biotech Co Ltd (2015–2026)
Market capitalization of Oneness Biotech Co Ltd from 2015 to today. Between 2015 and today, Oneness Biotech Co Ltd's market cap moved from $518.25 Million to $ 691.90 Million, with a yearly change of 3.57%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$691.90 Million | -17.63% |
| 2025 | NT$839.94 Million | -36.31% |
| 2024 | NT$1.32 Billion | -55.12% |
| 2023 | NT$2.94 Billion | -9.82% |
| 2022 | NT$3.26 Billion | -14.61% |
| 2021 | NT$3.82 Billion | +19.29% |
| 2020 | NT$3.20 Billion | +719.73% |
| 2019 | NT$390.18 Million | +12.43% |
| 2018 | NT$347.05 Million | +28.82% |
| 2017 | NT$269.41 Million | -40.82% |
| 2016 | NT$455.21 Million | -12.16% |
| 2015 | NT$518.25 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Oneness Biotech Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $691.90 Million USD |
| MoneyControl | $691.90 Million USD |
| MarketWatch | $691.90 Million USD |
| marketcap.company | $691.90 Million USD |
| Reuters | $691.90 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Oneness Biotech Co Ltd
Oneness Biotech Co., Ltd. engages in the research, development, and sale of new drugs, pharmaceuticals, and health products in Taiwan. It operates through New Drug Research and Development, and Agricultural Products Cultivation and Organic Food segments. The company offers Fespixon which is a treatment of diabetic foot ulcer; and Bonvadis, a wound care medical device. It also develops FB825, whic… Read more